Myelin-oligodendrocyte glycoprotein antibody-associated disease

R Marignier, Y Hacohen, A Cobo-Calvo… - The Lancet …, 2021 - thelancet.com
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …

[HTML][HTML] Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management

E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - Frontiers in …, 2022 - frontiersin.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …

[HTML][HTML] Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies

E Carnero Contentti, J Correale - Journal of neuroinflammation, 2021 - Springer
Neuromyelitis optica (NMO) is a chronic inflammatory autoimmune disease of the central
nervous system (CNS) characterized by acute optic neuritis (ON) and transverse myelitis …

Myelin oligodendrocyte glycoprotein antibodies in neurological disease

M Reindl, P Waters - Nature Reviews Neurology, 2019 - nature.com
Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) were first detected
by immunoblot and enzyme-linked immunosorbent assay nearly 30 years ago, but their …

[HTML][HTML] Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide

JY Hor, N Asgari, I Nakashima, SA Broadley… - Frontiers in …, 2020 - frontiersin.org
Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon inflammatory disease of
the central nervous system, manifesting clinically as optic neuritis, myelitis, and certain brain …

[HTML][HTML] MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

S Jarius, F Paul, O Aktas, N Asgari, RC Dale… - Journal of …, 2018 - Springer
Over the past few years, new-generation cell-based assays have demonstrated a robust
association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein …

Clinical presentation and prognosis in MOG-antibody disease: a UK study

M Jurynczyk, S Messina, MR Woodhall, N Raza… - Brain, 2017 - academic.oup.com
Abstract See de Seze (doi: 10.1093/brain/awx292) for a scientific commentary on this article.
A condition associated with an autoantibody against MOG has been recently recognized as …

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study

A Cobo-Calvo, A Ruiz, E Maillart, B Audoin, H Zephir… - Neurology, 2018 - AAN Enterprises
Objective To describe clinical and radiologic features associated with myelin
oligodendrocyte glycoprotein antibodies (MOG-Ab) in a large French nationwide adult …

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

S Ramanathan, S Mohammad, E Tantsis… - Journal of Neurology …, 2018 - jnnp.bmj.com
Objective We characterised the clinical course, treatment and outcomes in 59 patients with
relapsing myelin oligodendrocyte glycoprotein (MOG) antibody-associated demyelination …

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

DM Wingerchuk, B Banwell, JL Bennett, P Cabre… - Neurology, 2015 - AAN Enterprises
Neuromyelitis optica (NMO) is an inflammatory CNS syndrome distinct from multiple
sclerosis (MS) that is associated with serum aquaporin-4 immunoglobulin G antibodies …